Indo-Bangla Pharmaceuticals (DHA:IBP) Equity-to-Asset : 0.00 (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Indo-Bangla Pharmaceuticals's Total Stockholders Equity for the quarter that ended in . 20 was BDT0.00 Mil. Indo-Bangla Pharmaceuticals's Total Assets for the quarter that ended in . 20 was BDT0.00 Mil.

The historical rank and industry rank for Indo-Bangla Pharmaceuticals's Equity-to-Asset or its related term are showing as below:

DHA:IBP's Equity-to-Asset is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.59
* Ranked among companies with meaningful Equity-to-Asset only.

Indo-Bangla Pharmaceuticals Equity-to-Asset Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals Equity-to-Asset Chart

Indo-Bangla Pharmaceuticals Annual Data

Trend

Equity-to-Asset

Indo-Bangla Pharmaceuticals Semi-Annual Data

Equity-to-Asset

Competitive Comparison of Indo-Bangla Pharmaceuticals's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Indo-Bangla Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo-Bangla Pharmaceuticals's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo-Bangla Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Indo-Bangla Pharmaceuticals's Equity-to-Asset falls into.

Indo-Bangla Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Indo-Bangla Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )	=	Total Stockholders Equity	/	Total Assets
	=		/
	=

Indo-Bangla Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )	=	Total Stockholders Equity	/	Total Assets
	=		/
	=

Indo-Bangla Pharmaceuticals (DHA:IBP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Indo-Bangla Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229

Website

http://www.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.